Indication
Malignant neoplasm of gastroesophageal junction
A malignant neoplasm of the gastroesophageal junction is an aggressive cancer arising at the anatomical transition zone between the distal esophagus and the gastric cardia of the stomach. Read more about Malignant neoplasm of gastroesophageal junction
2 drugs 2 manufacturers
Drugs that treat it
Common Malignant neoplasm of gastroesophageal junction therapies.
LONSURF (trifluridine/tipiracil HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonA malignant neoplasm of the gastroesophageal junction is an aggressive cancer arising at the anatomical transition zone between the distal esophagus and the gastric cardia of the stomach.
Predominantly affecting adults—with a higher incidence in older males and individuals with chronic gastroesophageal reflux disease, obesity, or Barrett esophagus—the vast majority of these tumors are adenocarcinomas.
Pathophysiologically, persistent mucosal inflammation and acid-induced intestinal metaplasia lead to dysplastic transformation, local transmural invasion, and frequent lymphatic dissemination.
Patients commonly present with progressive dysphagia, unintentional weight loss, retrosternal pain, early satiety, and anemia secondary to chronic occult blood loss.
- nih.gov
A malignant neoplasm of the gastroesophageal junction is an aggressive cancer arising at the anatomical transition zone between the distal esophagus and the gastric cardia of the stomach
- nih.gov
A malignant neoplasm of the gastroesophageal junction is an aggressive cancer arising at the anatomical transition zone between the distal esophagus and the gastric cardia of the stomach Predominantly affecting adults—with a higher incidence in older males and individuals with chronic gastroesophageal reflux disease, obesity, or Barrett esophagus—the vast majority of these tumors are adenocarcinomas Pathophysiologically, persistent mucosal inflammation and acid-induced intestinal metaplasia lead...
- webmd.com
Predominantly affecting adults—with a higher incidence in older males and individuals with chronic gastroesophageal reflux disease, obesity, or Barrett esophagus—the vast majority of these tumors are adenocarcinomas Pathophysiologically, persistent mucosal inflammation and acid-induced intestinal metaplasia lead to dysplastic transformation, local transmural invasion, and frequent lymphatic dissemination Patients commonly present with progressive dysphagia, unintentional weight loss, retrosterna...
- nih.gov
Predominantly affecting adults—with a higher incidence in older males and individuals with chronic gastroesophageal reflux disease, obesity, or Barrett esophagus—the vast majority of these tumors are adenocarcinomas
- nih.gov
Pathophysiologically, persistent mucosal inflammation and acid-induced intestinal metaplasia lead to dysplastic transformation, local transmural invasion, and frequent lymphatic dissemination
- astrazeneca-us.com
Patients commonly present with progressive dysphagia, unintentional weight loss, retrosternal pain, early satiety, and anemia secondary to chronic occult blood loss
Personalize your experience
Follow Malignant neoplasm of gastroesophageal junction and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.